Overview
Transgenomic develops and commercializes molecular diagnostic tests and tools focused on genetic diseases, oncology, and rare inherited cardiac conditions.
More in Clinical Diagnostics
Latest industry news
Vietnam's Gene Solutions Eyes Hong Kong IPO to Fuel Regional Genomics Expansion
2026-10-26 · Industry
Regeneron's FDA-Approved Neurosensory Gene Therapy Signals a New Era for Genetic Medicine
2026-10-25 · Product
DNA Testing Technology Emerges as a New Frontier in Cold Case Investigations
2026-10-24 · Policy
Whole Genome Sequencing for the General Public: Is the Value Proposition Finally There?
2026-10-23 · Research
Company details
Category
🏥 Clinical Diagnostics
Location
Omaha, NE, USA
Funding
Publicly traded — NASDAQ: TBIO (acquired)
Website
www.transgenomic.comListed
2026-10-26
Is this your company?
Claim this listing to add your logo, full description, and products. Premium listings get featured placement.
Claim & upgrade listingAdvertise
Reach genomics professionals
Newsletter sponsorships, featured listings, and sponsored articles.
View packages →